Reported referral for genetic counseling or BRCA 1/2 testing among United States physicians: A vignette-based study

Cancer

Volumn 117, Issue 23, 2011, Pages 5334-5343

  Trivers, Katrina F ^a   Baldwin, Laura Mae ^b   Miller, Jacqueline W ^a   Matthews, Barbara ^b   Andrilla, C Holly A ^b   Lishner, Denise M ^b   Goff, Barbara A ^b  

^a NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

attitude of health personnel; attitudes; genetic testing; health knowledge; ovarian neoplasms; practice; primary health care

Indexed keywords

ADULT; AGE DISTRIBUTION; ARTICLE; CANCER RISK; CAUCASIAN; FAMILY MEDICINE; FEMALE; GENETIC COUNSELING; GENETIC SCREENING; GYNECOLOGY; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MEDICAID; MEDICAL SPECIALIST; NEGRO; ONCOGENE; OVARY CANCER; PATIENT REFERRAL; PHYSICIAN ATTITUDE; PRACTICE GUIDELINE; PRIORITY JOURNAL; PRIVATE HEALTH INSURANCE; RACE DIFFERENCE; RISK ASSESSMENT; SELF REPORT; SEX DIFFERENCE; UNITED STATES; URBAN RURAL DIFFERENCE; VIGNETTE;

ADULT; BREAST NEOPLASMS; FEMALE; GENES, BRCA1; GENES, BRCA2; GENETIC COUNSELING; GENETIC TESTING; GUIDELINE ADHERENCE; HUMANS; MALE; MIDDLE AGED; OVARIAN NEOPLASMS; PHYSICIAN'S PRACTICE PATTERNS; REFERRAL AND CONSULTATION; UNITED STATES;

EID: 81755161515     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.26166     Document Type: Article

References (39)

1. Chen S, Parmigiani G,. Meta-analysis of BRCA1 and BRCA2 penetrance. J Clin Oncol. 2007; 25: 1329-1333. (Pubitemid 46706879)
2. U.S. Preventive Services Task Force. Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: recommendation statement. Ann Intern Med. 2005; 143: 355-361.
3. Rebbeck TR, Friebel T, Lynch HT, et al. Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group. J Clin Oncol. 2004; 22: 1055-1062. (Pubitemid 41095038)
4. Rebbeck TR, Kauff ND, Domchek SM,. Meta-analysis of risk reduction estimates associated with risk-reducing salpingo-oophorectomy in BRCA1 or BRCA2 mutation carriers. J Natl Cancer Inst. 2009; 101: 80-87.
5. American College of Obstetricians and Gynecologists. ACOG Practice Bulletin No. 103: Hereditary breast and ovarian cancer syndrome. Obstet Gynecol. 2009; 113: 957-966.
6. American College of Medical Genetics. Genetic susceptibility to breast and ovarian cancer: assessment, counseling and testing guidelines 1999. Available at: Accessed March 16, 2010.
7. National Comprehensive Cancer Network. The NCCN 1.2010 clinical practice guidelines in oncology genetic/familial high-risk assessment: breast and ovarian. Available at: Accessed June 14, 2010.
8. Mouchawar J, Klein CE, Mullineaux L,. Colorado family physicians' knowledge of hereditary breast cancer and related practice. J Cancer Educ. 2001; 16: 33-37. (Pubitemid 32230506)
9. Meyer LA, Anderson ME, Lacour RA, et al. Evaluating women with ovarian cancer for BRCA1 and BRCA2 mutations: missed opportunities. Obstet Gynecol. 2010; 115: 945-952.
10. Guerra CE, Sherman M, Armstrong K,. Diffusion of breast cancer risk assessment in primary care. J Am Board Fam Med. 2009; 22: 272-279.
11. Doksum T, Bernhardt BA, Holtzman NA,. Does knowledge about the genetics of breast cancer differ between nongeneticist physicians who do or do not discuss or order BRCA testing? Genet Med. 2003; 5: 99-105. (Pubitemid 36992619)
12. Haas JS, Kaplan CP, Gregorich SE, Perez-Stable EJ, Des Jarlais G,. Do physicians tailor their recommendations for breast cancer risk reduction based on patient's risk? J Gen Intern Med. 2004; 19: 302-309. (Pubitemid 38530501)
13. Koil CE, Everett JN, Hoechstetter L, Ricer RE, Huelsman KM,. Differences in physician referral practices and attitudes regarding hereditary breast cancer by clinical practice location. Genet Med. 2003; 5: 364-369. (Pubitemid 37264985)
14. Wideroff L, Freedman AN, Olson L, et al. Physician use of genetic testing for cancer susceptibility: results of a national survey. Cancer Epidemiol Biomarkers Prev. 2003; 12: 295-303. (Pubitemid 36427989)
15. Acheson LS, Stange KC, Zyzanski S,. Clinical genetics issues encountered by family physicians. Genet Med. 2005; 7: 501-508. (Pubitemid 41447474)
16. Kaplan CP, Haas JS, Perez-Stable EJ, Des Jarlais G, Gregorich SE,. Factors affecting breast cancer risk reduction practices among California physicians. Prev Med. 2005; 41: 7-15. (Pubitemid 40755058)
17. Sabatino SA, McCarthy EP, Phillips RS, Burns RB,. Breast cancer risk assessment and management in primary care: provider attitudes, practices, and barriers. Cancer Detect Prev. 2007; 31: 375-383. (Pubitemid 350166789)
18. Shields AE, Burke W, Levy DE,. Differential use of available genetic tests among primary care physicians in the United States: results of a national survey. Genet Med. 2008; 10: 404-414.
19. White DB, Bonham VL, Jenkins J, Stevens N, McBride CM,. Too many referrals of low-risk women for BRCA1/2 genetic services by family physicians. Cancer Epidemiol Biomarkers Prev. 2008; 17: 2980-2986.
20. Burke W, Culver J, Pinsky L, et al. Genetic assessment of breast cancer risk in primary care practice. Am J Med Genet A. 2009; 149A: 349-356.
21. Samphao S, Wheeler AJ, Rafferty E, et al. Diagnosis of breast cancer in women age 40 and younger: delays in diagnosis result from underuse of genetic testing and breast imaging. Am J Surg. 2009; 198: 538-543.
22. Bellcross CA, Kolor K, Goddard KA, Coates RJ, Reyes M, Khoury MJ,. Awareness and utilization of BRCA1/2 testing among U.S. primary care physicians. Am J Prev Med. 2011; 40: 61-66.
23. Dillman DA,. Mail and internet surveys: the tailored design method. 2nd ed. Hoboken, NJ: John Wiley & Sons; 2007.
24. Morrill R, Cromartie J, Hart LG,. Metropolitan, urban, and rural commuting areas: toward a better depiction of the US settlement system. Urban Geography. 1999; 20: 727-748. (Pubitemid 30423400)
25. Economic Research Service. Measuring rurality: rural-urban commuting area codes. Available at: Accessed June 11, 2010.
26. Katz DA, Williams GC, Brown RL, et al. Emergency physicians' fear of malpractice in evaluating patients with possible acute cardiac ischemia. Ann Emerg Med. 2005; 46: 525-533. (Pubitemid 41676750)
27. Franks P, Williams GC, Zwanziger J, Mooney C, Sorbero M,. Why do physicians vary so widely in their referral rates? J Gen Intern Med. 2000; 15: 163-168. (Pubitemid 30155348)
28. Bieler GS, Brown GG, Williams RL, Brogan DJ,. Estimating model-adjusted risks, risk differences, and risk ratios from complex survey data. Am J Epidemiol. 2010; 171: 618-623.
29. Coughlin SS, Leadbetter S, Richards T, Sabatino SA,. Contextual analysis of breast and cervical cancer screening and factors associated with health care access among United States women, 2002. Soc Sci Med. 2008; 66: 260-275. (Pubitemid 350236484)
30. Vital signs: breast cancer screening among women aged 50-74 years-United States, 2008. MMWR Morb Mortal Wkly Rep. 2010; 59: 813-816.
31. Sabatino SA, Coates RJ, Uhler RJ, Breen N, Tangka F, Shaw KM,. Disparities in mammography use among US women aged 40-64 years, by race, ethnicity, income, and health insurance status, 1993 and 2005. Med Care. 2008; 46: 692-700.
32. Swan J, Breen N, Graubard BI, et al. Data and trends in cancer screening in the United States: results from the 2005 National Health Interview Survey. Cancer. 2010; 116: 4872-4881.
33. Meissner HI, Breen N, Taubman ML, Vernon SW, Graubard BI,. Which women aren't getting mammograms and why? (United States). Cancer Causes Control. 2007; 18: 61-70. (Pubitemid 46020902)
34. Etzioni DA, Ponce NA, Babey SH, et al. A population-based study of colorectal cancer test use: results from the 2001 California Health Interview Survey. Cancer. 2004; 101: 2523-2532. (Pubitemid 39532281)
35. Trivers KF, Shaw KM, Sabatino SA, Shapiro JA, Coates RJ,. Trends in colorectal cancer screening disparities in people aged 50-64 years, 2000-2005. Am J Prev Med. 2008; 35: 185-193.
36. Meissner HI, Tiro JA, Yabroff KR, Haggstrom DA, Coughlin SS,. Too much of a good thing? Physician practices and patient willingness for less frequent pap test screening intervals. Med Care. 2010; 48: 249-259.
37. Peabody JW, Luck J, Glassman P, Dresselhaus TR, Lee M,. Comparison of vignettes, standardized patients, and chart abstraction: a prospective validation study of 3 methods for measuring quality. JAMA. 2000; 283: 1715-1722. (Pubitemid 30196212)
38. Bellcross CA, Lemke AA, Pape LS, Tess AL, Meisner LT,. Evaluation of a breast/ovarian cancer genetics referral screening tool in a mammography population. Genet Med. 2009; 11: 783-789.
39. Watson E, Clements A, Yudkin P, et al. Evaluation of the impact of two educational interventions on GP management of familial breast/ovarian cancer cases: a cluster randomised controlled trial. Br J Gen Pract. 2001; 51: 817-821. (Pubitemid 32958618)